Amgen

Large Cap Biopharmaceuticals Are Core Holdings After Sell-Off: AbbVie, Amgen, Gilead
Seeking Alpha
Wed, 03/26/14 - 08:30 am
AbbVie
Amgen
Gilead Sciences
Achillion
Alexion
Ariad Pharmaceuticals
Pharmacyclics
Seattle Genetics
JPMorgan Sees No Bubble, Hears No Bubble as Biotech Falls Again
Barron's
Mon, 03/24/14 - 11:29 am
biotech
Biogen Idec
Amgen
Celgene
Gilead Sciences
Regeneron
Amgen drug meets goal for those with high genetic cholesterol
Yahoo/Reuters
Mon, 03/17/14 - 10:25 am
Amgen
cholesterol
evolocumab
Amgen's talimogene laherparepvec reduced size of tumors in Phase 3 study
Yahoo/The Fly on the Wall
Sat, 03/15/14 - 10:03 am
Amgen
Talimogene Laherparepvec
melanoma
With FDA Concerns Public, What's Next for These Cholesterol Drugs?
Motley Fool
Thu, 03/13/14 - 05:55 pm
FDA
Regeneron
Pfizer
Amgen
PCSK9 inhibitors
Better Buy: Biogen Or Amgen?
Motley Fool
Sat, 03/8/14 - 10:39 am
Amgen
Biogen
3 Stocks Boosting The Drugs Industry Higher
TheStreet.com
Thu, 02/27/14 - 05:00 pm
Intercept Pharma
Amgen
Pfizer
Pharma shelled out $3.75B in fraud penalties in record-setting year, feds say
Fierce Pharma
Wed, 02/26/14 - 11:12 am
fraud
Abbott Labs
Amgen
Ranbaxy
Wyeth
Pfizer
Sanofi
AbbVie, Amgen and Roche most vulnerable to biosim rivals, Moody's says
Fierce Pharma
Tue, 02/25/14 - 03:58 pm
AbbVie
Amgen
Roche
biosimilars
Biotech: Too Big for Its Britches?
Barron's
Mon, 02/24/14 - 05:05 pm
biotech
Celgene
Gilead Sciences
Biogen Idec
Amgen
Regeneron
Amgen Inc's Deep Pipeline Offsets Some of the Price Risk
Motley Fool
Wed, 02/12/14 - 10:07 am
Amgen
earnings
evolocumab
Frantic Pace In Cancer Immunotherapy: Merck Vs. Bristol-Myers
Seeking Alpha
Wed, 02/12/14 - 09:14 am
cancer immunotherapy
Merck
Bristol-Myers Squibb
Amgen
Incyte
Pfizer
MK-3475
Ablynx
Yervoy
Can drug makers find profit in collaboration?
Forbes
Tue, 02/11/14 - 04:45 pm
NIH
Bristol-Myers Squibb
Pfizer
GSK
Eli Lilly
Merck
Amgen
Why You Shouldn't Overlook Amgen, Inc.
Motley Fool
Tue, 02/11/14 - 09:57 am
Amgen
earnings
What to Watch at Amgen, Merck, Pfizer, and Myriad Genetics This Morning
Motley Fool
Wed, 02/5/14 - 10:24 am
Amgen
Merck
Pfizer
Myriad Genetics
Crescendo Biosciences
M&A
MK-3475
Merck Accelerates Cancer-Immunotherapy Program With Three Collaborations
TheStreet.com
Wed, 02/5/14 - 08:42 am
cancer immunotherapy
Merck
Amgen
Incyte
Pfizer
Bristol-Myers Squibb
MK-3475
Xgeva and Prolia: Setting the Pace for Amgen, Inc.
Motley Fool
Tue, 02/4/14 - 07:48 am
Xgeva
Prolia
Amgen
Can Biotech Dominate for a 4th Year in a Row?
Motley Fool
Mon, 02/3/14 - 09:35 am
biotech
IPOs
Amgen
Ariad Pharmaceuticals
Regeneron
Amgen Goes 6 for 6 Fighting Cholesterol
Motley Fool
Sat, 02/1/14 - 10:52 am
Amgen
cholesterol
hypercholesterolemia
evolocumab
Why Caution Is Prevailing in Biotechs Into and After Earnings
24/7 Wall St
Wed, 01/29/14 - 02:54 pm
biotech
Celgene
Biogen Idec
Amgen

Pages